12- Week Open Label Treatment of Refractory Bipolar Depression

NCT00223496 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Aripiprazole

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]